Korean Medication Algorithm for Bipolar Disorder 2018 : Mixed Features / 우울ㆍ조울병
Mood and Emotion
;
(2): 69-76, 2018.
Article
in Korean
| WPRIM
| ID: wpr-786882
ABSTRACT
OBJECTIVES:
The Korean Medication Algorithm for Bipolar Disorder 2018 (KMAP-BP 2018) has been revised again as a result of a consensus of opinions among experts. The mixed episode was changed to mixed features in DSM-5. In this study, we will describe the preference and recommendation of KMAP-BP 2018 for the treatment of mood episodes with mixed features.METHODS:
Out of 84 members of the review committee, 61 completed the survey. We analyzed the answers, discussed the data, and held a clinician hearing.RESULTS:
The preferred first-step strategies for mixed features with more manic symptoms were a combination of mood stabilizers (MS), atypical antipsychotics (AAP), and AAP monotherapy. For mixed features with more depressive symptoms, a combination of MS and lamotrigine (LTG), a combination of MS and AAP, and a combination of AAP and LTG were preferred. For mixed features with manic and depressive symptoms, a combination of MS and AAP, and AAP monotherapy were preferred.CONCLUSION:
For mixed features, a combination of MS and AAP was generally preferred, and lamotrigine was preferred for depressive symptoms. We hope this KMAP-BP 2018 to be helpful for clinicians that treat patients with bipolar disorder in Korea.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antipsychotic Agents
/
Bipolar Disorder
/
Advisory Committees
/
Consensus
/
Depression
/
Hope
/
Hearing
/
Korea
Type of study:
Practice guideline
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Asia
Language:
Korean
Journal:
Mood and Emotion
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS